Catecholamines profiles at diagnosis: Increased diagnostic sensitivity and correlation with biological and clinical features in neuroblastoma patients.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Neuroblastoma (NBL) accounts for 10% of the paediatric malignancies and is responsible for 15% of the paediatric cancer-related deaths. Vanillylmandelic acid (VMA) and homovanillic acid (HVA) are most commonly analysed in urine of NBL patients. However, their diagnostic sensitivity is suboptimal (82%). Therefore, we performed in-depth analysis of the diagnostic sensitivity of a panel of urinary catecholamine metabolites.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Eur. J. Cancer

Title: European journal of cancer (Oxford, England : 1990)

Publisher: Elsevier BV

ISSN (Electronic): 1879-0852

ISSN (Print): 0959-8049

Publication date (Electronic): February 2017

Volume: 72

Affiliations

[1 ] Department of Pediatric Oncology/Hematology, Emma Children's Hospital/Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Laboratory Genetic Metabolic Diseases, Emma Children's Hospital/Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Princess Máxima Center for Pediatric Oncology/Hematology, Lundlaan 6, 3584 EA Utrecht, The Netherlands.

[2 ] Laboratory Genetic Metabolic Diseases, Emma Children's Hospital/Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.

[3 ] Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Eindhovenweg 20, 2333 ZC Leiden, The Netherlands; Mathematical Institute, Leiden University, Niels Bohrweg 1, 2333 CA Leiden, The Netherlands.

[4 ] Princess Máxima Center for Pediatric Oncology/Hematology, Lundlaan 6, 3584 EA Utrecht, The Netherlands; University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.

[5 ] Department of Pediatric Oncology/Hematology, Sophia Children's Hospital/Erasmus Medical Center, Wytemaweg 80, 3015 CN Rotterdam, The Netherlands.

[6 ] Department of Pediatric Oncology/Hematology, VU University Medical Center, De Boelelaan 1118, 1081 HZ Amsterdam, The Netherlands.

[7 ] Department of Pediatric Oncology/Hematology, Emma Children's Hospital/Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.

[8 ] Department of Pediatric Oncology/Hematology, Emma Children's Hospital/Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Princess Máxima Center for Pediatric Oncology/Hematology, Lundlaan 6, 3584 EA Utrecht, The Netherlands. Electronic address: G.A.M.Tytgat@prinsesmaximacentrum.nl.

Article

Publisher Item ID: S0959-8049(16)33069-6

DOI: 10.1016/j.ejca.2016.12.002

PubMed ID: 28061374

SO-VID: 0545d589-2b1d-442b-b238-b11115220aa9

History

Keywords: Catecholamines,Diagnostic sensitivity,MIBG non-avid tumours,Neuroblastoma,VMA and HVA negative

Data availability:

Keywords: Catecholamines, Diagnostic sensitivity, MIBG non-avid tumours, Neuroblastoma, VMA and HVA negative

Catecholamines profiles at diagnosis: Increased diagnostic sensitivity and correlation with biological and clinical features in neuroblastoma patients.

Read this article at

Abstract

Related collections

ScienceOpen Clinical Case Reports Collection

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Similar content 75

Cited by 24